| NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients S Malhotra, C Costa, H Eixarch, CW Keller, L Amman, ... Brain 143 (5), 1414-1430, 2020 | 125 | 2020 |
| NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis S Malhotra, J Río, E Urcelay, R Nurtdinov, MF Bustamante, O Fernández, ... Brain 138 (3), 644-652, 2015 | 121 | 2015 |
| Locus for severity implicates CNS resilience in progression of multiple sclerosis MultipleMS Consortium Harroud Adil 1 78 78 Jónsdóttir Ingileif 74 75 Blanco ... Nature 619 (7969), 323-331, 2023 | 100 | 2023 |
| Genetic variants are major determinants of CSF antibody levels in multiple sclerosis A Goris, I Pauwels, MW Gustavsen, B Van Son, K Hilven, SD Bos, ... Brain 138 (3), 632-643, 2015 | 79 | 2015 |
| Targeting inflammasomes to treat neurological diseases JD Lünemann, S Malhotra, ML Shinohara, X Montalban, M Comabella Annals of neurology 90 (2), 177-188, 2021 | 73 | 2021 |
| MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis International Multiple Sclerosis Genetics Consortium Brain 136 (6), 1778-1782, 2013 | 73 | 2013 |
| Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis S Malhotra, MF Bustamante, F Pérez-Miralles, J Rio, MC Ruiz de Villa, ... PloS one 6 (8), e23634, 2011 | 59 | 2011 |
| A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis F Matesanz, V Potenciano, M Fedetz, P Ramos-Mozo, MM Abad-Grau, ... Human molecular genetics 24 (19), 5619-5627, 2015 | 57 | 2015 |
| Genome-wide significant association with seven novel multiple sclerosis risk loci CM Lill, F Luessi, A Alcina, EA Sokolova, N Ugidos, B de la Hera, ... Journal of medical genetics 52 (12), 848-855, 2015 | 47 | 2015 |
| Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon‐β treatment S Malhotra, C Morcillo‐Suárez, R Nurtdinov, J Rio, E Sarro, M Moreno, ... European Journal of Neurology 20 (10), 1390-1397, 2013 | 39 | 2013 |
| Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors R Cagliani, D Forni, M Biasin, M Comabella, FR Guerini, S Riva, ... Genome biology and evolution 6 (4), 830-845, 2014 | 37 | 2014 |
| Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course E Gil-Varea, E Urcelay, C Vilariño-Güell, C Costa, L Midaglia, F Matesanz, ... Journal of neuroinflammation 15, 1-10, 2018 | 34 | 2018 |
| Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis C Matute-Blanch, J Río, LM Villar, L Midaglia, S Malhotra, ... Journal of neuroimmunology 303, 62-65, 2017 | 33 | 2017 |
| TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis M Comabella, AB Caminero, S Malhotra, L Agulló, O Fernández, ... Neurology 80 (22), 2010-2016, 2013 | 33 | 2013 |
| Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study S Mahurkar, M Moldovan, V Suppiah, M Sorosina, F Clarelli, G Liberatore, ... The pharmacogenomics journal 17 (4), 312-318, 2017 | 32 | 2017 |
| Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis S Malhotra, N Fissolo, M Tintoré, AC Wing, J Castilló, A Vidal-Jordana, ... Journal of neuroinflammation 12, 1-5, 2015 | 32 | 2015 |
| Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β MF Bustamante, C Morcillo-Suárez, S Malhotra, J Rio, L Leyva, ... Neuroimmunology & Neuroinflammation 2 (5), e154, 2015 | 30 | 2015 |
| SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis S Malhotra, J Castilló, MF Bustamante, A Vidal-Jordana, Z Castro, ... Multiple Sclerosis Journal 19 (5), 524-531, 2013 | 29 | 2013 |
| NR1H3 p. Arg415Gln is not associated to multiple sclerosis risk J Antel, M Ban, S Baranzini, L Barcellos, N Barizzone, A Beecham, ... Neuron 92 (2), 333-335, 2016 | 25 | 2016 |
| Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles B Hera, E Urcelay, D Brassat, A Chan, A Vidal-Jordana, A Salmen, ... Neuroimmunology & Neuroinflammation 1 (4), e47, 2014 | 24 | 2014 |
Jordi RioServicio de Neurologia-Neuroinmunologia. Centro de esclerosis múltiple de Catalunya. Hospital Universitario Vall d'HebronVerified email at cem-cat.org